- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Late onset Pompe disease
- Meeting Date: March 2025
- Public Summary Document (PSD) March 2025 PBAC Meeting - (PDF)
- Public Summary Document (PSD) March 2025 PBAC Meeting - (Word)
Cipaglucosidase Alfa; Miglustat – March 2025
Cipaglucosidase Alfa; Powder for I.V. infusion 105 mg, Pombiliti®; Miglustat, Capsule 65 mg; Opfolda®
Last updated
12 March 2025